Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm

被引：0
|
作者：
Zibelman, Matthew [1 ]
Plimack, Elizabeth R. [1 ]
机构：
[1] Temple Hlth, Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
ONCOLOGY-NEW YORK | 2016年 / 30卷 / 02期
关键词：
BACILLUS-CALMETTE-GUERIN; BLADDER-CANCER; CTLA-4; BLOCKADE; MITOMYCIN-C; METAANALYSIS; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：160 / +
页数：4
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors for urothelial carcinoma
    Albertsen, Peter
    [J]. BJU INTERNATIONAL, 2023, 132 (01) : 3 - 3
  • [2] Immune checkpoint inhibitors for urothelial carcinoma
    Kim, Hyung Suk
    Seo, Ho Kyung
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2018, 59 (05) : 285 - 296
  • [3] Urothelial carcinoma in the era of immune checkpoint inhibitors
    Khalife, Nadine
    Chahine, Claude
    Kordahi, Manal
    Felefly, Tony
    Kourie, Hampig Raphael
    Saleh, Khalil
    [J]. IMMUNOTHERAPY, 2021, 13 (11) : 953 - 964
  • [4] Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer
    Katz, Heather
    Wassie, Emnet
    Alsharedi, Mohamed
    [J]. MEDICAL ONCOLOGY, 2017, 34 (10)
  • [5] Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer
    Heather Katz
    Emnet Wassie
    Mohamed Alsharedi
    [J]. Medical Oncology, 2017, 34
  • [6] Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma
    Powles, Tom
    Morrison, Laura
    [J]. NATURE REVIEWS UROLOGY, 2018, 15 (10) : 585 - 587
  • [7] The evolving role of checkpoint inhibitors in the treatment of urothelial carcinoma
    Tang, Guyu
    Liu, Jing
    Qi, Lin
    Li, Yuan
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 93 - 113
  • [8] The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Houssiau, Helene
    Seront, Emmanuel
    [J]. CANCERS, 2022, 14 (07)
  • [9] Biomarker challenges for immune checkpoint inhibitors in urothelial carcinoma
    Tom Powles
    Laura Morrison
    [J]. Nature Reviews Urology, 2018, 15 : 585 - 587
  • [10] Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors
    Qin, Qian
    Patel, Vaibhav
    Galsky, Matthew D.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 503 - 512
12345